MicroRNA and Gene Expression Changes in Parkinson’s Disease Patients Blood Leukocytes: A Short Communication
Received Date: Jun 02, 2022 / Published Date: Jul 05, 2022
Abstract
Parkinson’s disease has increasing prevalence worldwide. Several genes were identified as involved in the disease so far (e.g., Park, SNCA, MAPT, PINK1 as well as several molecular pathways (e.g., alternative spicing, metal ion channels, inflammation) but there are still mainly unknown genes involved in the disease. I previously applied SOLID small and long RNA-Seq, junction and exon arrays on PD patient’s and matching control samples. Furthermore, model MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine) mice studies found similar patterns in functional groups of genes (using Kolmogorov-Smirnov- KS statistical method. Subsequently, Gene Ontology (GO) functional analysis of Biological Processes (BP) and molecular functions. Additionally, PD RNA expression datasets can be compared to those from other neurodegenerative diseases including Alzheimer’s disease (AD) and Motor neuron disease. Also, stem cells from patients can be studied in parallel for RNA expression pattern changes through RNA-Seq or Cerebro Spinal Fluid (CSF).
Keywords:
Citation: Soreq L (2022) MicroRNA and Gene Expression Changes in Parkinson’s Disease Patients Blood Leukocytes: A Short Communication. J Alzheimers Dis Parkinsonism. 12:544. Doi: 10.4172/2161-0460.1000544
Copyright: © 2022 Soreq L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 1126
- [From(publication date): 0-2022 - Dec 23, 2024]
- Breakdown by view type
- HTML page views: 913
- PDF downloads: 213